Research graph
References from Analysis of gut microbiota and fecal/plasma short-chain fatty acids in non-dialysis renal anemia patients: associations with clinical parameters. Local targets link to admitted publications; unresolved targets remain external evidence.
Gut bacteria products prevent AKI induced by ischemia-reperfusion
10.1681/asn.2014030288 · 2015 · External reference
Mechanisms of anemia in CKD
10.1681/asn.2011111078 · 2012 · External reference
Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study
10.1113/jp272613 · 2017 · External reference
New treatment approaches for the Anemia of CKD
10.1053/j.ajkd.2015.06.030 · 2016 · External reference
The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development
10.1007/s10157-016-1255-y · 2017 · External reference
Association of Fecal and Plasma Levels of short-chain fatty acids with gut microbiota and clinical severity in patients with Parkinson disease
10.1212/wnl.0000000000013225 · 2022 · External reference
Therapeutic effects of butyrate on pediatric obesity: a randomized clinical trial
10.1001/jamanetworkopen.2022.44912 · 2022 · External reference
Regulation of immune cell function by short-chain fatty acids
10.1038/cti.2016.17 · 2016 · External reference
Short chain fatty acids in human large intestine, portal, hepatic and venous blood
10.1136/gut.28.10.1221 · 1987 · External reference
Microbial metabolite signaling is required for systemic iron homeostasis
10.1016/j.cmet.2019.10.005 · 2020 · External reference
Microbiota and metabolome associated with immunoglobulin a nephropathy (IgAN)
10.1371/journal.pone.0099006 · 2014 · External reference
The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism
10.1194/jlr.r036012 · 2013 · External reference
Prevalence, etiology, and consequences of anemia and clinical and economic benefits of anemia correction in patients with chronic kidney disease: an overview
10.2146/ajhp070181 · 2007 · External reference
Commensal microbiota regulates T cell fate decision in the gut
10.1007/s00281-014-0455-3 · 2015 · External reference
The metabolic sensor GPR43 receptor plays a role in the control of Klebsiella pneumoniae infection in the lung
10.3389/fimmu.2018.00142 · 2018 · External reference
Hypoxia-inducible factor prolyl hydroxylase inhibitors: a potential new treatment for anemia in patients with CKD
10.1053/j.ajkd.2016.12.011 · 2017 · External reference
Gut microbial metabolites SCFAs and chronic kidney disease
10.1186/s12967-024-04974-6 · 2024 · External reference
Fecal microbiota characteristics of Chinese patients with primary IgA nephropathy: a cross-sectional study
10.1186/s12882-020-01741-9 · 2020 · External reference
The intestinal microbiota and metabolites in the gut-kidney-heart Axis of chronic kidney disease
10.3389/fphar.2022.837500 · 2022 · External reference
Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in kenyan infants
10.1136/gutjnl-2014-307720 · 2015 · External reference
Anaemia, iron deficiency and susceptibility to infections
10.1016/j.jinf.2014.08.007 · 2014 · External reference
Acetate attenuates kidney fibrosis in an oxidative stress-dependent manner
10.14814/phy2.15774 · 2023 · External reference
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
10.1016/j.kint.2023.10.018 · 2024 · External reference
Systemic concentrations of short chain fatty acids are elevated in salmonellosis and exacerbation of familial Mediterranean fever
10.3389/fmicb.2016.00776 · 2016 · External reference
The gut-kidney Axis: putative interconnections between gastrointestinal and renal disorders
10.3389/fendo.2018.00553 · 2018 · External reference
Dietary fiber protects against diabetic nephropathy through short-chain fatty acid–mediated activation of G protein–coupled receptors GPR43 and GPR109A
10.1681/asn.2019101029 · 2020 · External reference
Prevalence, awareness, and treatment of anemia in Chinese patients with nondialysis chronic kidney disease: first multicenter, cross-sectional study
10.1097/md.0000000000003872 · 2016 · External reference
The relationships among gut microbiota, hypoxia-inducible factor and anaemia with chronic kidney disease
10.1111/nep.14064 · 2022 · External reference
Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure
10.1093/ndt/gfh1032 · 2004 · External reference
Altered gut microbiota and microbial biomarkers associated with chronic kidney disease
10.1002/mbo3.678 · 2019 · External reference
The role and mechanisms of gut microbiota in diabetic nephropathy, diabetic retinopathy and cardiovascular diseases
10.3389/fmicb.2022.977187 · 2022 · External reference
Anemia in infancy is associated with alterations in systemic metabolism and microbial structure and function in a sex-specific manner: an observational study
10.1093/ajcn/nqy249 · 2018 · External reference
Intestinal microbiome and fitness in kidney disease
10.1038/s41581-019-0172-1 · 2019 · External reference
Targeting lactobacillus johnsonii to reverse chronic kidney disease
10.1038/s41392-024-01913-1 · External reference
Lactobacillus species ameliorate membranous nephropathy through inhibiting the aryl hydrocarbon receptor pathway via tryptophan-produced indole metabolites
10.1111/bph.16219 · External reference
Anemia is correlated with malnutrition and inflammation in Croatian peritoneal dialysis patients: a multicenter nationwide study
10.3747/pdi.2016.00013 · 2017 · External reference
Alterations of the human gut microbiome in chronic kidney disease
10.1002/advs.202001936 · 2020 · External reference
Anti-inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL-12 and up-regulation of IL-10 production
10.1096/fj.00-0359fje · 2000 · External reference
Bacterial metabolites and cardiovascular risk in children with chronic kidney disease
10.1186/s40348-021-00126-8 · 2021 · External reference
The effects of Spirulina on anemia and immune function in senior citizens
10.1038/cmi.2010.76 · 2011 · External reference
Short-chain fatty acid transporters: role in colonic homeostasis
10.1002/cphy.c170014 · 2017 · External reference
The clinical and economic burden of anemia
2010 · External reference
Gut microbiome-short-chain fatty acids interplay in the context of iron deficiency anaemia
10.1007/s00394-021-02645-6 · 2022 · External reference
Gut microbiome-derived short-chain fatty acids in glomerular protection and modulation of chronic kidney disease progression
10.3390/nu17172904 · 2025 · External reference
Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease
10.3748/wjg.v13.i20.2826 · 2007 · External reference
Introduction to the human gut microbiota
10.1042/bcj20160510 · 2017 · External reference
KDIGO 2026 clinical practice guideline for the management of anemia in chronic kidney disease (CKD)
10.1016/j.kint.2025.06.006 · 2026 · External reference
Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis
10.1038/nm.3444 · 2014 · External reference
The controversial role of human gut Lachnospiraceae
10.3390/microorganisms8040573 · 2020 · External reference
Burden of illness for patients with non-dialysis chronic kidney disease and anemia in the United States: review of the literature
10.3111/13696998.2010.484307 · 2010 · External reference
Chronic kidney disease alters intestinal microbial flora
10.1038/ki.2012.345 · 2013 · External reference
Dietary fiber and the short-chain fatty acid acetate promote resolution of neutrophilic inflammation in a model of gout in mice
10.1189/jlb.3a1015-453rrr · 2017 · External reference
Quantitative reduction in short-chain fatty acids, especially butyrate, contributes to the progression of chronic kidney disease
10.1042/cs20190171 · 2019 · External reference
Gut microbiota as diagnostic tools for mirroring disease progression and circulating Nephrotoxin levels in chronic kidney disease: discovery and validation study
10.7150/ijbs.37421 · 2020 · External reference
The prebiotic effects of oats on blood lipids, gut microbiota, and short-chain fatty acids in mildly hypercholesterolemic subjects compared with rice: a randomized, controlled trial
10.3389/fimmu.2021.787797 · 2021 · External reference
The gut microbiota and the brain-gut-kidney axis in hypertension and chronic kidney disease
10.1038/s41581-018-0018-2 · 2018 · External reference
Sodium butyrate improves renal injury in diabetic nephropathy through AMPK/SIRT1/PGC-1α signaling pathway
10.1038/s41598-024-68227-8 · 2024 · External reference
Renal anemia of inflammation: the name is self-explanatory
10.1159/000328037 · 2011 · External reference
Roxadustat alleviates the inflammatory status in patients receiving maintenance hemodialysis with erythropoiesis-stimulating agent resistance by increasing the short-chain fatty acids producing gut bacteria
10.1186/s40001-023-01179-3 · 2023 · External reference
Specific alterations in gut microbiota in patients with chronic kidney disease: an updated systematic review
10.1080/0886022x.2020.1864404 · 2021 · External reference
Natural products from plants and microorganisms: novel therapeutics for chronic kidney disease via gut microbiota regulation
10.3389/fphar.2022.1068613 · 2023 · External reference
Modifications of gut microbiota are associated with the severity of IgA nephropathy in the Chinese population
10.1016/j.intimp.2020.107085 · 2020 · External reference
Probiotic treatment induces changes in intestinal microbiota but does not alter SCFA levels in peritoneal dialysis patients—a randomized, placebo-controlled trial
10.1038/s41598-024-83056-5 · 2024 · External reference
